HPV Vaccination When Young Cuts Cervical Cancer Risk by 87%
Latest Cancer News THURSDAY, Nov. 4, 2021 (HealthDay News) The sooner girls are vaccinated against human papillomavirus (HPV), the lower their future risk of cervical cancer, a new study finds. Compared to unvaccinated women, the risk of cervical cancer was 87% lower among those who received the bivalent vaccine Cervarix at ages 12 […]
Experimental drug boosts immunotherapy effectiveness in pancreatic cancer in mice
An experimental drug enhanced the benefit of an immunotherapy to fight pancreatic cancer in mice by increasing the number of immune cells in the immediate vicinity of the tumor, leading to a reduction in tumor growth, and in some mice, eliminating their cancer. The findings, from researchers at Georgetown Lombardi Comprehensive Cancer Center and BioXcel […]
Time for Targeted PSA Screening for Men With Rare Pathogenic Variants?
Men with certain pathogenic variants had a higher incidence of prostate cancer versus age-matched controls, and may be candidates for targeted prostate-specific antigen (PSA) screening, according to findings from the IMPACT trial. In the international, prospective study, men with confirmed pathogenic variants in mismatch repair (MMR) genes who underwent one screening round had a higher […]
Colon Cancer Diagnoses Fell 40% in Pandemic, and That’s Not Good News
Latest Cancer News MONDAY, Oct. 4, 2021 (HealthDay News) Colon cancer numbers dropped dramatically during the COVID-19 pandemic, but that doesn’t mean fewer people have the disease. In Spain, researchers discovered a more than 40% decline in colon cancer diagnoses, leading experts to worry about the ramifications. “These are very worrying findings indeed […]
Existing Drugs Could Treat Lung Cancer in Nonsmokers
Latest Cancer News MONDAY, Oct. 4, 2021 There’s some encouraging news for people who develop lung cancer even though they’ve never smoked. Precision drugs already approved by the U.S. Food and Drug Administration can be used to treat 78% to 92% of their tumors, a new study reports. These precision drugs target specific […]
One-Word Change in Prostate Cancer Guideline Has Some Urologists in Arms
The National Comprehensive Cancer Network (NCCN) is under fire for removing active surveillance’s (AS) “preferred” status in its low-risk prostate cancer guidelines. AS has been listed as preferred since 2019, and the change puts it on par with radical prostatectomy and radiation therapy in this patient population. Edward “Ted” Schaeffer, MD, PhD, chairman of the […]
Risk of Premature Death Seen in Testicular Cancer Survivors
Treating testicular cancer (TC) with platinum-based chemotherapy (PBCT) and radiotherapy (RT) was associated with an increased risk of long-term non-TC mortality, a Norwegian population-based cohort study found. Over a median follow-up of 18.7 years, overall excess non-TC mortality was 23% in men diagnosed with TC compared with the general population (standardized mortality ratio [SMR] 1.23, […]
Too Many Black Men Are Dying From Prostate Cancer
Prostate cancer remains the second highest cancer-related cause of death in men in the U.S., and there has been a worrisome trend of rising metastatic disease at diagnosis. These facts make it increasingly important that the urological community and the patients we serve turn our attention to ways to overcome these challenges. The Role of […]
Most cases of never-smokers’ lung cancer treatable with mutation-targeting drugs: Available, FDA-approved drugs may be effective in targeting about 80% of never-smokers’ lung tumors
Despite smoking’s well-known role in causing lung cancer, a significant number of patients who develop lung tumors have never smoked. While scientists are still working to understand what spurs cancer in so-called “never-smokers,” a study led by scientists at Washington University School of Medicine in St. Louis demonstrates new possibilities for treating these baffling tumors. […]
How high-fat diets allow cancer cells to go unnoticed
A high-fat diet increases the incidence of colorectal cancer. Cold Spring Harbor Laboratory Fellow Semir Beyaz and collaborators from Harvard Medical School and Massachusetts Institute of Technology have discovered that in mice, fat disrupts the relationship between intestinal cells and the immune cells that patrol them looking for emerging tumors. Reconfiguring the gut microbiome may […]